Population differences in the use of EGFR-targeted agents.
Saijo
Nagahiro
N
The Japanese Society of Medical Oncology, Chiba, Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D005006:Ethnicity / Q000235:genetics; D005828:Genetics, Population; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors